OliX Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11,056	6,359	3,883	11,983	4,930	34,337
Short-Term Investments	87,769	91,900	-	10,000	53,000	15,000
Trading Asset Securities	9,569	34,255	8,531	3,942	3,941	420.68
Cash & Short-Term Investments	108,394	132,513	12,414	25,925	61,872	49,757
Cash Growth	839.66%	967.42%	-52.11%	-58.10%	24.35%	-26.95%
Accounts Receivable	-0	5,127	95.11	3,558	53.23	-
Other Receivables	1,821	1,115	907.84	1,419	996.88	272.13
Receivables	1,821	6,242	1,003	4,977	1,050	491.49
Inventory	418.41	396.71	554.26	468.41	657.17	374.13
Prepaid Expenses	1,884	1,566	1,370	244.9	1,367	1,480
Other Current Assets	19,662	134.21	192.88	526.86	99	136.92
Total Current Assets	132,179	140,851	15,534	32,142	65,046	52,240
Property, Plant & Equipment	50,492	50,499	51,385	43,910	37,232	31,525
Long-Term Investments	1,392	1,352	1,986	23,481	26,809	0.5
Other Intangible Assets	1,919	1,944	1,705	1,981	2,107	2,134
Other Long-Term Assets	367.51	719.66	639.62	1,312	1,458	772.05
Total Assets	186,349	195,366	71,249	102,825	132,651	86,672
Accrued Expenses	400.78	738.78	488.52	465.36	358.62	297.85
Short-Term Debt	-	644	13,441	-	-	-
Current Portion of Long-Term Debt	3,571	3,571	3,572	-	19,230	16,405
Current Portion of Leases	423.76	318.3	745.85	1,065	939.87	487.8
Current Income Taxes Payable	-	2.81	53.77	-	-	-
Other Current Liabilities	15,650	16,051	11,759	5,033	19,014	23,174
Total Current Liabilities	20,046	21,326	30,060	6,563	39,543	40,365
Long-Term Debt	16,964	17,857	21,428	35,362	20,000	20,326
Long-Term Leases	834.15	895.92	5.38	2,930	3,826	51.69
Pension & Post-Retirement Benefits	-	-	414.47	-	-	225.41
Other Long-Term Liabilities	3,115	5,208	867.98	7,634	3,080	6,296
Total Liabilities	40,959	45,287	52,777	52,489	66,449	67,265
Common Stock	10,150	10,095	9,230	8,010	6,852	6,852
Additional Paid-In Capital	327,654	323,423	175,533	157,177	151,895	92,908
Retained Earnings	-201,378	-191,586	-167,785	-122,910	-103,224	-84,303
Comprehensive Income & Other	7,252	6,458	871.87	7,141	8,885	3,064
Total Common Equity	143,678	148,390	17,849	49,418	64,407	18,521
Minority Interest	721.77	699.37	623.76	481.45	295.16	886.27
Shareholders' Equity	145,390	150,079	18,473	50,336	66,203	19,407
Total Liabilities & Equity	186,349	195,366	71,249	102,825	132,651	86,672
Total Debt	21,793	23,287	39,192	39,357	43,996	37,271
Net Cash (Debt)	86,601	109,227	-26,778	-13,433	17,876	12,487
Net Cash Growth	-	-	-	-	43.16%	-76.70%
Net Cash Per Share	4216.05	5553.79	-1589.86	-930.93	1304.50	912.36
Filing Date Shares Outstanding	22.2	20.19	18.46	16.02	13.7	13.7
Total Common Shares Outstanding	22.2	20.19	18.46	16.02	13.7	13.7
Working Capital	112,133	119,525	-14,526	25,578	25,502	11,874
Book Value Per Share	6470.68	7349.70	966.92	3084.79	4700.19	1351.59
Tangible Book Value	141,759	146,445	16,144	47,437	62,300	16,387
Tangible Book Value Per Share	6384.24	7253.40	874.55	2961.16	4546.39	1195.84
Land	25,325	25,325	25,460	25,740	25,740	25,740
Buildings	22,690	22,690	23,033	3,354	3,354	3,354
Machinery	8,160	7,659	7,425	6,436	5,518	4,427
Construction In Progress	158	169.57	-	8,948	1,239	71.73